Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Tuesday, 03'rd Dec 2024
SAN FRANCISCO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, d
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Tuesday, 03'rd Dec 2024
WALTHAM, Mass and DUBLIN, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:10pm, Tuesday, 03'rd Dec 2024
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options
SPS Commerce to Present at the Nasdaq 51st Investor Conference
04:06pm, Tuesday, 03'rd Dec 2024
MINNEAPOLIS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will present at the Nasdaq 51st Invest
Qurate Retail, Inc. Transfers Equity Listing to the Nasdaq Capital Market
04:05pm, Tuesday, 03'rd Dec 2024
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Qurate Retail, Inc. Transfers Equity Listing to the Nasdaq Capital Market.
EA to Present at the Nasdaq 51st Investor Conference
04:05pm, Tuesday, 03'rd Dec 2024
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Electronic Arts Inc. (NASDAQ: EA) today announced that Stuart Canfield, CFO, will present at the Nasdaq 51st Investor Conference on Tuesday, December 10, in Lond
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 03'rd Dec 2024
BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 03'rd Dec 2024
CAMBRIDGE, Mass. , Dec. 3, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, gran
Sprouts Farmers Market to Present at the Nasdaq 51st Annual Investor Conference
04:02pm, Tuesday, 03'rd Dec 2024
PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM), one of the largest and fastest-growing specialty retailers of fresh, natural and organic food in the United States, today announce
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Tuesday, 03'rd Dec 2024
CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based thera
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Tuesday, 03'rd Dec 2024
SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent s
New Calamos ETFs Offer S&P 500 & Nasdaq-100 Exposure
08:05am, Tuesday, 03'rd Dec 2024
Calamos Investments expanded its lineup of Structured Protection ETFs with the launch of two new funds, providing exposure to S&P 500 and Nasdaq-100 with 100% downside protection over one year: Calamo
AgriFORCE Announces Reverse Stock Split for Nasdaq Compliance
07:30am, Tuesday, 03'rd Dec 2024
VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI), an intellectual property focused agtech company, today announced the C
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Tuesday, 03'rd Dec 2024
BOSTON--(BUSINESS WIRE)--Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, toda
Billionaires Are Piling Into This Nasdaq Stock-Split Company Down 52% and Yielding a Healthy 4% Dividend
06:15am, Tuesday, 03'rd Dec 2024
In case you missed it, institutional funds recently disclosed their latest equity holdings for the third quarter of the year in their 13F forms filed with the Securities and Exchange Commission (SEC).
